13G Filing: Sabby Capital and Trovagene Inc. (TROV)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Sabby Volatility Warrant Master Fund, Ltd 0 2,124,250 0 2,124,250 2,124,250 5.70%
Sabby Management 0 2,124,250 0 2,124,250 2,124,250 5.70%
Hal Mintz 0 2,124,250 0 2,124,250 2,124,250 5.70%
Hal Mintz
Hal Mintz
Sabby Capital

Page 1 of 7 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.________)*

Trovagene Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

897238309
(CUSIP Number)

July 13, 2017
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
[_] Rule 13d-1(b)

[X] Rule 13d-1(c)

[_] Rule 13d-1(d)

__________
*The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover
page.
The information required in the remainder of this cover page shall
not be deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
?
CUSIP No.
897238309

Follow Cardiff Oncology Inc. (NASDAQ:CRDF)